A global cancer surveillance framework within noncommunicable disease surveillance: Making the case for population-based cancer registries

Epidemiologic Reviews

Volumn 39, Issue 1, 2017, Pages 161-169

  Piñeros, Marion ^a   Znaor, Ariana ^a   Mery, Les ^a   Bray, Freddie ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Neoplasms; Noncommunicable diseases; Registries; Surveillance; World health

Indexed keywords

ARTICLE; CANCER CONTROL; CANCER EPIDEMIOLOGY; CANCER REGISTRY; CANCER SURVIVAL; COMMUNICABLE DISEASE; DISEASE SURVEILLANCE; MALIGNANT NEOPLASM; NON COMMUNICABLE DISEASE; PRIORITY JOURNAL; RISK FACTOR; VITAL STATISTICS; EPIDEMIOLOGICAL MONITORING; GLOBAL HEALTH; HEALTH SURVEY; HUMAN; NEOPLASM; REGISTER; WORLD HEALTH ORGANIZATION;

COMMUNICABLE DISEASES; EPIDEMIOLOGICAL MONITORING; GLOBAL HEALTH; HUMANS; NEOPLASMS; NONCOMMUNICABLE DISEASES; PUBLIC HEALTH SURVEILLANCE; REGISTRIES; WORLD HEALTH ORGANIZATION;

EID: 85020403806     PISSN: 0193936X     EISSN: 14786729     Source Type: Journal    
DOI: 10.1093/epirev/mxx003     Document Type: Article

References (80)

1. Caldwell JC. Population health in transition. Bull World Health Organ. 2001;79(2):159-160.
2. McKeown RE. The epidemiologic transition: changing patterns of mortality and population dynamics. Am J Lifestyle Med. 2009;3(1 suppl):19S-26S.
3. Santosa A, Wall S, Fottrell E, et al. The development and experience of epidemiological transition theory over four decades: A systematic review. Glob Health Action. 2014;7: 23574.
4. World Health Organization. Global Health Observatory (GHO) data: NCD mortality and morbidity. http://www.who.int/gho/ncd/mortality-morbidity/en/Updated 2016. Accessed May 2, 2016.
5. Bray F, Soerjomataram I. The changing global burden of cancer: Transitions in human development and implications for cancer prevention and control. In: Gelband H, Jha P, Sankaranarayanan R, et al, eds. Cancer: Disease Control Priorities. Washington, DC: International Bank for Reconstruction and Development, The World Bank; 2015: 23-45.
6. World Health Organization. Draft Comprehensive Global Monitoring Framework and Targets for the Prevention and Control of NCDs. Geneva, Switzerland: World Health Organization; 2013.
7. World Health Organization. World economic forum: from burden to "best buys": Reducing the economic impact of non-communicable diseases in low-And middle-income countries. http://www.who.int/nmh/publications/best-buys-summary.pdf?ua=1 Published 2011. Accessed February 9, 2016.
8. World Health Organization. Global Status Report on Noncommunicable Diseases 2014. Geneva, Switzerland: World Health Organization; 2014.
9. Bray F, Znaor A, Cueva P, et al. Planning and Developing Population-Based Cancer Registration in Low-And Middle-Income Settings. Lyon, France: International Agency for Research on Cancer; 2014.
10. International Agency for Research on Cancer. Global initiative for cancer registry development. http://gicr.iarc.fr/fr/Published 2015. Accessed April 29, 2015.
11. Teutsch SM. Considerations in planning a surveillance system. In: Lee LM, Teutsch SM, Thacker SB, et al, eds. Principles and Practice of Public Health Surveillance. 3rd ed. New York, NY: Oxford University Press, Inc; 2010.
12. Thacker SB. Historical development. In: Lee LM, Teutsch SM, Thacker SB, et al, eds. Principles and Practice of Public Health Surveillance. 3rd ed. New York, NY: Oxford University Press, Inc; 2010.
13. World Health Organization. Global action plan for the prevention and control of noncommunicable diseases 2013-2020. http://apps.who.int/iris/bitstream/10665/94384/1/9789241506236-eng.pdf?ua=1 Published 2013. Accessed February 9, 2016.
14. Remington PL, Nelson DE. Communicating public health surveillance information for action. In: Lee LM, Teutsch SM, Thacker SB, et al, eds. Principles and Practice of Public Health Surveillance. 3rd ed. New York, NY: Oxford University Press, Inc; 2010.
15. Centers for Disease Control and Prevention. Field Epidemiology Training Program (FETP). http://www.cdc.gov/globalhealth/healthprotection/fetp/Published 2016. Accessed May 31, 2016.
16. St. Louis ME, Walke H, Perry H, et al. Surveillance in low-resource settings. In: Lee LM, Teutsch SM, Thacker SB, et al, eds. Principles and Practice of Public Health Surveillance. 3rd ed. New York, NY: Oxford University Press, Inc; 2010.
17. Shaw FE, Goodman RA, Lindegren ML, et al. A history of MMWR. MMWR Suppl. 2011;60(4):7-14.
18. Mendis S. The contribution of the Framingham Heart Study to the prevention of cardiovascular disease: A global perspective. Prog Cardiovasc Dis. 2010;53(1):10-14.
19. Keys A. Coronary heart disease in seven countries. 1970. Nutrition. 1997;13(3):250-252.
20. Armstrong T, Bonita R. Capacity building for an integrated noncommunicable disease risk factor surveillance system in developing countries. Ethn Dis. 2003;13(2 suppl 2): S13-S18.
21. Warren CW, Lee J, Lea V, et al. Evolution of the Global Tobacco Surveillance System (GTSS) 1998-2008. Glob Health Promot. 2009;16(2 suppl):4-37.
22. Riley L, Guthold R, Cowan M, et al. The World Health Organization STEPwise approach to noncommunicable disease risk-factor surveillance: methods, challenges, and opportunities. Am J Public Health. 2016;106(1):74-78.
23. Ballotari P, Chiatamone RS, Vicentini M, et al. Building a population-based diabetes register: An Italian experience. Diabetes Res Clin Pract. 2014;103(1):79-87.
24. Borg S, Palaszewski B, Gerdtham UG, et al. Patient-reported outcome measures and risk factors in a quality registry: A basis for more patient-centered diabetes care in Sweden. Int J Environ Res Public Health. 2014;11(12):12223-12246.
25. Hallgren Elfgren IM, Grodzinsky E, Törnvall E. Swedish Diabetes Register, a tool for quality development in primary health care. Prim Health Care Res Dev. 2013;14(3):250-257.
26. Jo EC, Drury PL. Development of a virtual diabetes register using information technology in New Zealand. Healthc Inform Res. 2015;21(1):49-55.
27. Centers for Disease Control and Prevention. National diabetes statistics report 2014. http://www.cdc.gov/diabetes/data/statistics/2014statisticsreport.html. Updated 2015. Accessed February 10, 2016.
28. International Diabetes Federation. IDF Diabetes Atlas. 7th ed. Brussels, Belgium: International Diabetes Federation; 2015. 29.
29. Taylor R, Zimmet P, Naseri T, et al. Erroneous inflation of diabetes prevalence: Are there global implications? J Diabetes. 2016;8(6):766-769.
30. Zimmet P, Alberti KG, Magliano DJ, et al. Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nat Rev Endocrinol. 2016;12(10):616-622.
31. Fritz A, Percy C, Jack A, et al. International Classification of Diseases for Oncology (ICD-O). 3rd ed, 1st rev ed. Geneva, Switzerland: World Health Organization; 2013.
32. Wild CP, Bray F, Forman D, et al. Cancer in the 25 × 25 non-communicable disease targets. Lancet. 2014;384(9953): 1502-1503.
33. Wild CP, Bucher JR, de Jong BW, et al. Translational cancer research: balancing prevention and treatment to combat cancer globally. J Natl Cancer Inst. 2015;107(1):353.
34. Vineis P, Wild CP. Global cancer patterns: causes and prevention. Lancet. 2014;383(9916):549-557.
35. Glaser SL, Clarke CA, Gomez SL, et al. Cancer surveillance research: A vital subdiscipline of cancer epidemiology. Cancer Causes Control. 2005;16(9):1009-1019.
36. Parkin DM. The role of cancer registries in cancer control. Int J Clin Oncol. 2008;13(2):102-111.
37. Devesa SS, Bray F, Vizcaino AP, et al. International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer. 2005;117(2):294-299.
38. Lortet-Tieulent J, Soerjomataram I, Ferlay J, et al. International trends in lung cancer incidence by histological subtype: Adenocarcinoma stabilizing in men but still increasing in women. Lung Cancer. 2014;84(1):13-22.
39. Pesch B, Kendzia B, Gustavsson P, et al. Cigarette smoking and lung cancer-relative risk estimates for the major histological types from a pooled analysis of case-control studies. Int J Cancer. 2012;131(5):1210-1219.
40. Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers -A different disease. Nat Rev Cancer. 2007;7(10):778-790.
41. Zanetti R, Schmidtmann I, Sacchetto L, et al. Completeness and timeliness: cancer registries could/should improve their performance. Eur J Cancer. 2015;51(9):1091-1098.
42. Parkin DM. The evolution of the population-based cancer registry. Nat Rev Cancer. 2006;6(8):603-612.
43. Wingo PA, Howe HL, Thun MJ, et al. A national framework for cancer surveillance in the United States. Cancer Causes Control. 2005;16(2):151-170.
44. Poole C. A history of the population attributable fraction and related measures. Ann Epidemiol. 2015;25(3):147-154.
45. Soerjomataram I, Lortet-Tieulent J, Ferlay J, et al. Estimating and validating disability-Adjusted life years at the global level: A methodological framework for cancer. BMC Med Res Methodol. 2012;12:125.
46. Arnold M, Pandeya N, Byrnes G, et al. Global burden of cancer attributable to high body-mass index in 2012: A population-based study. Lancet Oncol. 2015;16(1):36-46.
47. de Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: A review and synthetic analysis. Lancet Oncol. 2012;13(6):607-615.
48. Soerjomataram I, Lortet-Tieulent J, Parkin DM, et al. Global burden of cancer in 2008: A systematic analysis of disability-Adjusted life-years in 12 world regions. Lancet. 2012;380(9856):1840-1850.
49. Boyle P. Relative value of incidence and mortality data in cancer research. Recent Results Cancer Res. 1989;114:41-63.
50. Ellis L, Woods LM, Esteve J, et al. Cancer incidence, survival and mortality: Explaining the concepts. Int J Cancer. 2014; 135(8):1774-1782.
51. Berrino F, Micheli A, Sant M, et al. Interpreting survival differences and trends. Tumori. 1997;83(1):9-16.
52. Dickman PW, Adami HO. Interpreting trends in cancer patient survival. J Intern Med. 2006;260(2):103-117.
53. World Bank, World Health Organization. Global Civil Registration and Vital Statistics: Scaling Up Investment Plan 2015-2024. Washington, DC: World Bank Group; 2014.
54. Bloomberg MR, Bishop J. Understanding death, extending life. Lancet. 2015;386(10003):e18-e19.
55. Streatfield PK, Khan WA, Bhuiya A, et al. Cause-specific mortality in Africa and Asia: Evidence from INDEPTH health and demographic surveillance system sites. Glob Health Action. 2014;7:25362.
56. Jha P. Reliable direct measurement of causes of death in lowand middle-income countries. BMC Med. 2014;12:19.
57. Forman D, Bray F, Brewster D, et al. Cancer Incidence in Five Continents. Vol 10. Lyon, France: International Agency for Research on Cancer; 2014.
58. World Health Organization, International Agency for Research on Cancer. WHO cancer mortality database. http://www-dep.iarc.fr/WHOdb/WHOdb.htm. Accessed May 11, 2014.
59. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5): E359-E386.
60. International Agency for Research on Cancer. Global cancer observatory. http://gco.iarc.fr/Published 2016. Accessed May 30, 2016.
61. Allemani C, Weir HK, Carreira H, et al. Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25, 676, 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015;385(9972): 977-1010.
62. Coleman MP, Quaresma M, Berrino F, et al. Cancer survival in five continents: A worldwide population-based study (CONCORD). Lancet Oncol. 2008;9(8):730-756.
63. Sankaranarayanan R, Swaminathan R, Brenner H, et al. Cancer survival in Africa, Asia, and Central America: A population-based study. Lancet Oncol. 2010;11(2):165-173.
64. Sankaranarayanan R. Cancer survival in Africa, Asia, the Caribbean and Central America. Introduction. IARC Sci Publ. 2011;(162):1-5.
65. Armstrong BK. The role of the cancer registry in cancer control. Cancer Causes Control. 1992;3(6):569-579.
66. International Cancer Control Partnership. National plans. http://www.iccp-portal.org/map Published 2016. Accessed June 14, 2016.
67. de Vries E, Pardo C, Henriquez G, et al. Discrepancies in the handling of cancer data in Colombia [in Spanish]. Rev Colomb Cancerol. 2016;20(1):45-47.
68. Jensen OM, Parkin DM, Maclennan R, et al, eds. Cancer Registration: Principles and Methods. Lyon, France: International Agency for Research on Cancer; 1995.
69. Bray F, Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. Part I: Comparability, validity and timeliness. Eur J Cancer. 2009;45(5):747-755.
70. Parkin DM, Bray F. Evaluation of data quality in the cancer registry: principles and methods. Part II: Completeness. Eur J Cancer. 2009;45(5):756-764.
71. Chen W, Zheng R, Zeng H, et al. Annual report on status of cancer in China, 2011. Chin J Cancer Res. 2015;27(1):2-12.
72. Eser S, Yakut C, Özdemir R, et al. Cancer incidence rates in Turkey in 2006: A detailed registry based estimation. Asian Pac J Cancer Prev. 2010;11(6):1731-1739.
73. Ministerio da Saude, Instituto Nacional de Câncer José Alencar Gomes da Silva. Cancer Incidence in Brazil [in Portuguese]. Rio de Janeiro, Brazil: Instituto Nacional de Câncer José Alencar Gomes da Silva; 2015.
74. Pardo Ramos C, Cendales Duarte R. Estimated Incidence and Mortality From Cancer in Colombia 2002-2006. 2nd ed [in Spanish]. Bogotá, Colombia: National Institute of Cancerology; 2010.
75. Jedy-Agba EE, Oga EA, Odutola M, et al. Developing national cancer registration in developing countries-case study of the Nigerian national system of cancer registries. Front Public Health. 2015;3:186.
76. Hadji M, Nahvijou A, Seddighi Z, et al. Challenges to promoting population-based cancer registration in Iran: A workshop report. Asian Pac J Cancer Prev. 2013;14(10): 6189-6193.
77. O'Brien KS, Soliman AS, Awuah B, et al. Establishing effective registration systems in resource-limited settings: cancer registration in Kumasi, Ghana. J Registry Manag. 2013;40(2):70-77.
78. Pardo C, Bravo LE, Uribe C, et al. Comprehensive assessment of population-based cancer registries: An experience in Colombia. J Registry Manag. 2014;41(3):128-134.
79. Piñeros M, Pardo C, Gamboa O, et al. Atlas of Cancer Mortality in Colombia. 3rd ed [in Spanish]. Bogotá, Colombia: Instituto Geográfico Agustín Codazzi; 2010.
80. Singh E, Ruff P, Babb C, et al. Establishment of a cancer surveillance programme: The South African experience. Lancet Oncol. 2015;16(8):e414-e421.